J Gynecol Oncol.
2021 Jan;32(1):e19. 10.3802/jgo.2021.32.e19.
Why was GOG-0213 a negative trial?
- Affiliations
-
- 1Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen Mitte (KEM), Essen, Germany
- 2Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- KMID: 2526288
- DOI: http://doi.org/10.3802/jgo.2021.32.e19
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Present status and future direction of clinical trials in advanced endometrial carcinoma
- Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment
- New paradigm of intraperitoneal chemotherapy in ovarian carcinoma
- Radiotherapeutic management in carcinoma of the uterine cervix: GOG experience
- Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus
